APOPTOSIS AND DISEASE: Regulation and Clinical Relevance of Programmed Cell Death

Annual Review of Medicine - Tập 48 Số 1 - Trang 267-281 - 1997
Charles M. Rudin1, Craig B. Thompson1
1Gwen Knapp Center for Lupus and Immunology Research and the Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois 60637

Tóm tắt

▪ Abstract  Regulation of the homeostatic balance between cell proliferation and cell death is essential for development and maintenance of multicellular organisms. Physiologic, or programmed, cell death is dependent on a genetically encoded and evolutionarily conserved pathway that induces a form of cellular suicide known as apoptosis. In the past decade, it has become clear that the regulatory mechanisms controlling programmed cell death are as fundamental, and as complex, as those regulating cell proliferation. Perturbation of the signaling cascades regulating apoptosis, whether by extracellular triggers, acquired or germline genetic mutations, or viral mimicry of signaling molecules, can result in a wide variety of human diseases. Analysis of these regulatory pathways has led to a better understanding of the etiology and pathogenesis of many human diseases, notably cancers, infectious diseases including AIDS, autoimmune diseases, and neurodegenerative/neurodevelopmental diseases. Our understanding of the regulation of programmed cell death in health and disease is far from complete, and the challenge of converting that understanding into new therapeutic modalities has only begun to be approached.

Từ khóa


Tài liệu tham khảo

10.1126/science.8098552

10.1002/art.1780371002

10.1016/0006-3223(94)91241-6

10.1016/0959-437X(94)90100-7

10.1016/0092-8674(94)90518-5

10.1016/S0074-7696(08)62312-8

10.1073/pnas.83.14.5214

10.1016/0092-8674(93)90508-N

10.1073/pnas.90.8.3516

Lin EY, 1993, J. Immunol., 151, 1979, 10.4049/jimmunol.151.4.1979

10.1016/0092-8674(93)90509-O

10.1016/0092-8674(95)90411-5

10.1038/374731a0

10.1038/374733a0

10.1038/374736a0

10.1073/pnas.91.20.9238

10.1073/pnas.92.17.7834

10.1038/369321a0

10.1002/j.1460-2075.1995.tb00246.x

Boyd JM, 1995, Oncogene, 11, 1921

10.1038/356494a0

10.1016/0092-8674(94)90506-1

10.1038/381335a0

10.1146/annurev.bb.24.060195.003143

10.1016/0092-8674(93)90485-9

10.1101/gad.10.5.578

10.1016/S1074-7613(00)80428-8

10.1074/jbc.271.44.27863

10.1016/0092-8674(94)90303-4

10.1074/jbc.270.9.4312

10.1016/S0092-8674(94)90422-7

Fernandes-Alnemri T, 1995, Cancer Res., 55, 2737

10.1016/0092-8674(95)90490-5

10.1126/science.7535475

10.1038/376037a0

10.1016/0092-8674(95)90541-3

10.1038/371346a0

10.1101/gad.9.5.509

Eischen CM, 1994, J. Immunol., 153, 1947, 10.4049/jimmunol.153.5.1947

10.1002/j.1460-2075.1994.tb06459.x

10.1056/NEJM199606273342607

10.1016/0092-8674(95)90071-3

10.1016/0092-8674(95)90072-1

10.1016/0092-8674(95)90070-5

10.1016/S0092-8674(00)80984-8

10.1016/S0092-8674(00)81265-9

10.1016/S0092-8674(00)81266-0

10.1016/1074-7613(95)90142-6

10.1038/380075a0

10.1126/science.271.5250.808

10.1016/0092-8674(94)90532-0

10.1016/0092-8674(95)90489-1

10.1126/science.7533327

Hu HM, 1994, J. Biol. Chem., 269, 30069, 10.1016/S0021-9258(18)43772-6

10.1016/0014-5793(94)01406-Q

10.1074/jbc.270.43.25715

10.1074/jbc.271.22.12852

10.1126/science.7544915

10.1016/0092-8674(94)90202-X

10.1073/pnas.90.18.8479

Nielan JG, 1993, J. Virol., 67, 4391, 10.1128/jvi.67.7.4391-4394.1993

10.1016/0092-8674(91)90007-L

10.1016/0092-8674(92)90223-Y

10.1126/science.7569933

10.1016/0092-8674(95)90461-1

10.1016/0092-8674(95)90149-3

10.1002/j.1460-2075.1996.tb00629.x

10.1038/379349a0

10.1073/pnas.93.10.4974

10.1038/359552a0

10.1016/0092-8674(93)90719-7

10.1016/0092-8674(94)90534-7

10.1146/annurev.cb.10.110194.000245

10.1038/359328a0

10.1038/359288a0

10.1038/359295a0

10.1016/S0092-8674(00)81254-4

10.1016/S0092-8674(00)81255-6

10.1056/NEJM199310283291807

10.1126/science.7973635

Miyashita T, 1992, Cancer Res., 52, 5407

10.1182/blood.V81.1.151.151

Walton MI, 1993, Cancer Res., 53, 1853

Fisher TC, 1993, Cancer Res., 53, 3321

Dole M, 1994, Cancer Res., 54, 3253

Datta R, 1995, Cell Growth Differ., 6, 363

10.1182/blood.V86.5.1903.bloodjournal8651903

10.1182/blood.V81.11.3091.3091

Olopade OI, 1996, ASCO Proc., 15, 162

Webb A, 1996, Ann. Oncol., 7, 32, 10.1093/annonc/7.suppl_3.32

10.1126/science.7509084

10.1038/335445a0

10.1084/jem.176.4.1099

10.1126/science.7716549

Thông tin
Thông tin xuất bản

Annual Review of Medicine

Tập 48 Số 1

267-281

Thông tin tác giả